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A recent study proposed that liver transplantation may represent
life-saving treatment in patients with severe alcoholic hepatitis
not responding to medical therapy. In this pilot experience, strin-
gent patient selection resulted in major improvement of short-
term survival with low rates of post-transplant alcohol relapse.
In the context of organ shortage, which imposes a need for strict
selection of transplant candidates, these results raisemajor ethical
questions. Reluctance to perform liver transplantation in alcohol-
ics is based on the fact that alcoholism is frequently considered
to be self-inﬂicted and on fears of harmful post-transplant alcohol-
ism recurrence. A minimal interval of sobriety lasting at least
6 months is a widely adopted criterion for the selection of patients
with alcoholic liver disease for liver transplantation. In severe alco-
holic hepatitis, the disastrous short-term prognosis in patients not
responding to medical therapy does not allow one to reasonably
impose an arbitrary period of 6-months of abstinence. This means
that these patients must be either systematically excluded from
transplantation or selected according to other criteria. Without
signiﬁcant pre-transplant abstinence, itmight be argued that these
patients do not merit a graft as they have not demonstrated their
ability to gain control over their disease through durablemodiﬁca-
tion of their behaviour. Consequently, this procedure could have a
negative impact in the public, affecting organ donation and conﬁ-
dence in the fairness of transplant programs. In contrast, ethical
principles recommend active treatment of patients, without dis-
crimination, according to the best scientiﬁc knowledge. At this
stage, we propose that there are no major ethical barriers for fur-
ther evaluation of this new therapeutic option. The next steps
should include transparent communication with the public and
further studies to reproduce these results and identify the selec-
tion criteria that provide the best long-term outcomes.Journal of Hepa
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The lack of available organs for transplantation imposes a need to
deﬁne priorities for graft allocation and creates a situation in
which the objectives of equity, justice, utility, and beneﬁt are fre-
quently in conﬂict and impossible to fully reconcile. As transplan-
tation is, in many cases, a life-saving procedure, the selection of
transplant recipients is a crucial question, integrating major eth-
ical aspects. Such dilemmas, where optimal individual treatment
cannot be provided to each patient, are not unique in modern
medical practice. These choices are made in similar cases where
ﬁnancial limitations exist in many parts of the world, such as in
cases where patients lack medical insurance or do not have the
ability to pay for the costs of medical care. It is therefore a pri-
mary necessity for the transplant community to establish a fair
system for organ allocation and to deﬁne the selection criteria
for admission to transplantation waiting lists. This will require
regular re-evaluation of the criteria used for selection and prior-
itization of organ recipients, and veriﬁcation of the adequacy of
the system based on patient outcomes. There is also a need for
clear deﬁnition of the desirable end-points, which may vary from
the evaluation of primary disease recurrence, to graft and patient
survival, or to social re-integration. In addition, these reﬂections
must be shared with the public who are central actors in the suc-
cess of transplantation programs as organ donors and providers
of the health care system. It is in this context that a pilot study
recently evaluated the role of early liver transplantation (LT) in
treatment of patients with severe alcoholic hepatitis (SAH) not
responding to medical therapy [1]. In this indication, LT was per-
formed rapidly after the diagnosis of alcohol-induced life-threat-
ening liver failure, without respect to the broadly-accepted rule
that 6 months of alcohol sobriety must be achieved before a
patient is accepted onto a waiting list for LT. As might be
expected, this new therapeutic proposal created vigorous discus-
sions within the institutions involved in the study and in the
transplantation community. The central point of controversy is
the question of the fairness of the allocation of scarce transplan-
tation resources to patients who have not demonstrated a period14 vol. 60 j 866–871
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of abstinence from alcohol. Reluctance to adopt these programs
is, in part, related to concerns about the risk of harmful alcohol
relapse after LT, potentially leading to the waste of a precious
organ. Further, some people believe that these patients do not
deserve a transplant, as their condition is often considered to
be self-inﬂicted and patients at this advanced stage have not con-
vincingly shown repentance for their behaviour by demonstrat-
ing an ability to gain control over their disease. These debates,
concerning patients with SAH, and the broader group of patients
with alcoholic liver disease (ALD), trigger fundamental ethical
questions about the selection of patients for transplantation.
These include a necessity to respect the right of each individual
to be treated without discrimination, the interpretation of notions
such as the merit to be treated, the responsibilities of the medical
community to the public, the relationship between public
opinion and medical decisions, and ﬁnally, the potential conﬂicts
between moral and ethical positions in the context of medicine.Patients with severe alcoholic hepatitis not responding to
medical therapy as potential candidates for liver
transplantation
SAH is a well-deﬁned entity, corresponding to clear clinical,
biological, and histological criteria [2]. Alcoholic hepatitis (AH)
is a clinical syndrome associated with recent onset of jaundice
and/or ascites in a patient with ongoing alcohol abuse, and
characterized, at the histological level, by the presence of stea-
tosis, hepatocyte balonization, and inﬂammatory inﬁltrate [3].
Severity of AH can be objectively graded, on the basis of labo-
ratory data, using the Maddrey function [4]. SAH is deﬁned by a
Maddrey discriminant function P32 and is associated with a
high risk of early mortality [4]. Among patients with SAH, med-
ical therapies, particularly corticosteroids, have proven effective
in reducing mortality [5–7]. However, the prognosis remains
very poor for patients not responding to medical therapy with
6-month mortality rates of 75% [8]. The majority of these
deaths occur in the ﬁrst 3 months [8]. A major step forward
for the management of SAH has been the development of the
Lille Model, which allows rapid evaluation of the response to
treatment on the basis of bilirubin level evolution at day 7
[8]. It is in the subgroup of patients, identiﬁed by the Lille
Model as presenting with SAH not responding to medical ther-
apy, that LT was ﬁrst advocated [9] and then evaluated [1]. Not
surprisingly, in these patients, LT provided a highly signiﬁcant
short-term survival advantage as compared with a matched
group of non-transplanted patients [1]. In transplanted patients,
the 6-month survival rate was 77% as compared with 23% in
control patients and 90% of deaths in this last group occurred
within 2 months after the identiﬁcation of the non-response
to medical therapy. This beneﬁt was maintained at 2 years in
transplanted patients, with overall survival reaching 71%. Cer-
tainly, longer follow-up is required to recommend LT as an
option in these patients but these results serve as a proof of
concept for further evaluations. Importantly from an ethical
point of view, this also means that LT was performed in
approximately 25% of the SAH cohort who would have recov-
ered despite failing medical therapy, raising the issue of provid-
ing a liver graft to someone who was destined to recover and
underlining the need for other predictive markers of early mor-
tality in this setting.Journal of Hepatology 201The 6-month rule and other potential selection criteria for
liver transplantation in patients with severe alcoholic
hepatitis not responding to medical therapy
In current practice, compliance in patients with ALD who are can-
didates for LT is predominantly evaluated by their presumed
capacity to remain abstinent after transplant. In the selection
process, a patient’s adhesion to this principle can be considered
to be part of a contract with his treatment team. The rule that
6 months of alcohol abstinence is required before acceptance to
the LT list is broadly applied worldwide and has two main objec-
tives: First, to challenge a patient’s motivation and to identify
those that will remain abstinent after LT, and second, to evaluate
the possibility for stabilization or improvement of liver function,
which may eventually obviate the need for further LT. The valid-
ity of the 6-month rule has been recently debated in the litera-
ture [10]. Several weaknesses of this criterion have been
shown, including its arbitrary duration, limited speciﬁcity [11],
limited predictive value [11–13], and the fact that it does not
consider the presence of other predictive factors associated with
alcohol relapse, such as drug dependence, tobacco use, or depres-
sion [12]. Still, on a consensual basis, 6 months of abstinence
remains accepted as obligatory for listing ALD patients for LT.
In addition, some may argue that the ability to respect the 6-
month abstinence period is a necessary step toward reassuring
the community that the patient merits a transplant [14]. While
this concept is debatable, it widely exists in the medical commu-
nity and in the public, inﬂuencing, at least subliminally, the entire
discussion about the fairness of LT in patients with ALD. For
patients with SAH not responding to medical therapy, however,
the question relies more on the applicability of the 6-month rule
than on its validity. In these patients, both objectives of an obser-
vational period before transplant decision are essentially elusive
when one takes into account the nearly 70% mortality rate at
3 months and the very small chance for spontaneous clinical
improvement. Realistic options are, therefore, either to systemat-
ically deny these patients for transplantation or to evaluate other
potential selection criteria that can be obtained in a time period
compatible with rapid therapeutic decision. In the ﬁrst prospec-
tive study in patients with SAH not responding to medical ther-
apy, strict selection criteria were applied, including ﬁrst liver
decompensation, strong familial support, absence of psychiatric
disorders, and expressed adherence to lifelong complete alcohol
abstinence programs [1]. The selection was based on meetings
of multidisciplinary groups that included physicians, specialists
in addiction, patients, and family members. In these patients,
after a follow-up ranging from 2 to 3 years, alcohol relapse after
LT was 11%. Importantly, none of these recurrences occurred in
the ﬁrst 6 months, corresponding to the period classically used
to select LT candidates [1]. These selection criteria were extre-
mely restrictive, taking into account the fact that this was a pilot
study and, at this point, additional work is needed to assess their
reproducibility. Restricting inclusion to patients in their ﬁrst epi-
sode of decompensation is based on the concept that patients
who had previous episodes of liver failure deliberately chose to
ignore a warning. This is ethically questionable as it introduces
a judgmental aspect to the therapeutic decision, leading to dis-
tinct treatments for patients with the same disease based on their
different behaviours. In addition, group decision making itself
carries its own limitations, as it may be inﬂuenced by individual
authorities, potentially leading to some form of subjectivity [15].4 vol. 60 j 866–871 867
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Although this ﬁrst prospective study has not validated selection
criteria in these patients, it has opened the door to the possibility
that LT may be considered an option in highly selected patients,
for whom no real therapeutic alternative exists. These data
should be now conﬁrmed by other groups and additional work
is necessary to reﬁne these selection criteria. This is the aim of
an ongoing multicentre prospective study [16]. In parallel to this,
an accurate deﬁnition of selection criteria requires a precise and
consensual identiﬁcation of the end-points to be reached after
transplantation. In ALD, including in SAH, a provocative question
concerns the real necessity for exclusion of patients predicted to
be at risk of any alcohol relapse from LT programs. In a strict util-
itarian view, it may be argued that the primary objective of organ
transplantation is to achieve satisfactory long-term graft and
patient survival, irrespective of any other considerations. Such a
utilitarian end-point may appear limiting but has the clear
advantage of being easily, objectively, and transparently evalu-
able. In this regard, a particular question in ALD is the relation
between post-transplant alcohol consumption, and graft and
patient outcomes. A correlation between alcohol recidivism and
impaired long-term survival has been observed, but mostly due
to increased incidence of malignancy and cardiovascular events
rather than to toxic effects of alcohol on the liver graft [17]. In
this setting, the discriminatory value of the 6-month rule is lim-
ited, as duration of pre-transplant abstinence does not correlate
with post-transplant survival [18]. Several studies have demon-
strated no direct deleterious effects of alcohol drinking on post-
transplant outcomes, including therapeutic compliance, graft
function, and graft survival [17,19], while others have reported
negative impacts of heavy drinking on outcomes [20]. These con-
ﬂicting data underline the need for better distinction of the dif-
ferent types of alcohol drinking after transplantation, ranging
from occasional to moderate or severe, when alcohol habits could
correspond to use, abuse, or dependence. This also explains the
wide variation among post-LT alcohol relapse rates reported in
the literature, ranging from 20 to 50%, and the rates of heavy
drinking, which range from 10 to 20% [17,21–25]. In fact, similar
rates of any alcohol use have been reported in patients trans-
planted for ALD and for non-ALD, but the risk of heavy drinking
appears much higher in ALD patients [12]. Therefore, in order
to proceed with a utilitarian objective, the key would be to iden-
tify the predictive factors for harmful recurrent drinking after
transplantation. Among patients with ALD, these factors have
not been established and one might wonder if the pilot experi-
ence in SAH could not be extended to evaluate the added predic-
tive value of criteria such as psycho-social environment,
supportive willingness of the family, and systematic multidisci-
plinary reviewing, as compared with the strict application of a
mandatory duration for abstinence before listing. Another level
of confusion is related to the heterogeneity of the means for mon-
itoring alcohol use in patients on waiting lists [26,27]. This issue
has been partially addressed in retrospective studies evaluating
the impact of the presence of histological features of AH on liver
explant [28–30]. As histological features of alcoholic hepatitis
may persist for a prolonged period after alcohol withdrawal
[31], histological observations cannot be systematically inter-
preted to be the result of the presence or absence of abstinence
before LT and are not directly pertinent in the context of SAH.
Still, some authors consider the presence of these histological
changes to be a marker for clandestine drinking in patients listed
for LT [32] and, it could be reasonably assumed that at least a pro-868 Journal of Hepatology 201portion of these patients had recently drunk alcohol while on the
waiting list. Importantly, these studies showed that graft and
patient survival were not affected by the presence of histological
changes of AH on the explant as compared with control patients
transplanted for alcoholic cirrhosis [28,29]. With regard to post-
LT alcohol use, there was a tendency to higher relapse in patients
with histological AH, for which a majority reported heavy drink-
ing [28]. Taken together, if every effort is made to minimize the
risk for alcohol relapse after LT, this does not mean that any form
of post-transplant alcohol use corresponds per se to a failure of
the selection process and of the treatment as its impact closely
depends on the type of consumption. The importance given to
the risk for post-LT alcohol recurrence in general and its role as
a major barrier for development of LT programs in patients with
SAH in particular, may also rely on emotional factors. In this set-
ting, an obvious comparison can be made with patients with hep-
atitis C (HCV)-related liver disease, a non-controversial indication
for LT. In HCV patients, viral recurrence is almost universal and 5-
year cirrhosis recurrence reaches 20 to 30% [33], leading to 5- and
10-year survivals of 67% and 54%, respectively. This is signiﬁ-
cantly inferior to the 73% and 58% obtained in patients trans-
planted for ALD [34,35]. Yet, in contrast with post-LT disease
recurrence in HCV or in hepatocellular carcinoma, alcohol use
after having received a graft for SAH is often interpreted as a
breach of contract, vexatious, and hurtful for transplant profes-
sionals, and, more importantly, disrespectful for the organ
donors.Potential negative impacts on organ donation
Negative public perception of the use of LT in patients with SAH
has the potential to negatively impact organ donation. Reluctance
to share collective resources for treatment of alcoholic people has
been illustrated in surveys showing that potential donor families
might refuse organ donation if it is possible that the recipient
could be an alcoholic patient [36]. In addition, the attribution of
grafts to SAH patients could create a strong impression of injus-
tice because, in MELD-based allocation systems, these patients
are transplanted with a high degree of priority, before other can-
didates, including ALD patients selected according to the 6-
month criteria. In this situation, however, the risk for a loss of
conﬁdence from the public to the transplant practitioners should
be weighed against ethical requirements. It was recently stated in
the Declaration of Istanbul that: ‘‘Organs for transplantation
should be equitably allocated within countries or jurisdictions
to suitable recipients without regard to gender, ethnicity, reli-
gion, or social or ﬁnancial status’’ [37]. This general recommenda-
tion was not addressed to the problem of alcoholism, but
extended to the present discussion, this could be interpreted to
mean that potential transplant candidates should not be discrim-
inated against on the basis of their previous individual and social
behaviours unless those behaviours have a clear predicted impact
on graft outcomes. Undoubtedly, in the public and in the medical
community, alcoholic people suffer from very poor image
[36,38,39]. Whether this should inﬂuence organ allocation is
debatable but it should be acknowledged that this would repre-
sent a form of discrimination based on moral rather than medical
criteria. It is possible that reactive opinions from the public could
be balanced by transparent communication about SAH that high-
lights two aspects of the disease: First, that a disastrous prognosis4 vol. 60 j 866–871
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can be accurately and objectively predicted in a small subset of
patients, and second, that these patients should not be catego-
rized as non-compliant and actively drinking, but rather as
patients in whom compliance must be evaluated by other means
than a prolonged period of abstinence. An unequivocal distinc-
tion should be made, therefore, between evaluation of compli-
ance in SAH patients and failure of pre-transplant abstinence in
patients with alcoholic cirrhosis who were previously informed
of this requirement for listing. Moreover, the public’s lack of
esteem for alcoholic people does not mean that these patients
are systematically excluded from general empathy. This has been
illustrated recently by the massive outpouring of emotion in the
UK when a young patient with SAH was denied LT on the basis of
the 6-month rule and ﬁnally died [40]. Opinions in this debate
were contradictory, but interestingly, some of the arguments that
were used in the press to plea for transplantation, such as igno-
rance of previous liver disease and good familial support, were
identical to selection criteria used in the multicentre study [1].
Along the same lines, it should be noted that among different
European countries the rates of organ donation are not correlated
with the stringency of the selection. In the UK, where criteria for
LT are restrictive and alcoholic hepatitis is speciﬁed as a contra-
indication, the donation rate remains low as compared with other
countries in which such contraindication is not mentioned.The notion of merit to be treated
The notion of merit for access to medical treatment represents a
fundamental issue here. As the entire care system, particularly
transplant programs, is primarily built on community support,
the concept that patients with disrespectful social comportments
may be less deserving of treatment than others could under-
standably emerge. In much of our society, morality remains pro-
foundly inspired by Judeo-Christian principles. Individual and
societal comportments are frequently judged through distinc-
tions of good and bad, and faults are considered to be justiﬁcation
for some form of chastisement. Alcoholism is largely perceived to
be a self-chosen condition with negative consequences for the
entire society and is therefore considered a faulty behaviour.
Therefore, some consider that patients who develop liver failure
‘‘through no fault of their own’’ should have a higher priority
for transplant than those whose disease results from misconduct
[32]. Accordingly, if disease in this case appears to be a form of
natural punishment, restricted access to medical treatment, such
as transplantation, would constitute a second punishment, as it is
now imposed in a concerted way by society on the basis of judg-
mental and moral criteria. In this view, transplantation is a priv-
ilege, but not a right, and pre-transplant abstinence represents
some form of expiation, necessary to regain society’s conﬁdence
and access to treatment. The concept that alcoholism is a self-
inﬂicted disease is highly debatable. Alcoholism results from a
combination of many factors and the consequences of alcohol
intoxication depend on individual variation including genetic
predisposition [41]. Therefore, a susceptible individual cannot
be considered to be entirely responsible for alcoholism that leads
to liver failure. Several other liver diseases that eventually lead to
LT can also be considered self-inﬂicted, including viral hepatitis
in intravenous drug users, obesity, or paracetamol intoxication.
As an example, in patients with acute liver failure related to par-
acetamol overdose, independently of interpretation about aJournal of Hepatology 201patient’s complicity in his disease, the indication for LT strictly
relies on prognostic scores identifying the patients that will die
without transplantation. Remarkably, in patients with SAH, the
Lille Model is similarly able to determine the outcome and partic-
ularly the risk of rapid death. Still, the distinction of meritorious
and non-meritorious patients is widely shared by society and the
medical world. Studies that surveyed physicians and the public,
found that patients with ALD were placed at a very low level of
priority for transplantation, independently of their disease and
prognosis, just above the people in prison for violence [36,38].
Interestingly, this opinion was almost equally prevalent among
the public, general practitioners, and gastroenterologists. Such a
position implies that, comparable to deprivation of the civil rights
of criminals, alcoholics are considered to be responsible for delin-
quent acts and should be deprived of the right to be treated. This
represents a central aspect of the present discussion: To refuse
treatment to a patient on judgmental or moral bases would cor-
respond in fact to denying the fundamental human right of every
individual to be treated without discrimination (The Universal
Declaration of Human Rights, article 25) [42]. It would confer
to the transplant professional a judgmental position, in profound
contradiction with the objective of a fair system for organ alloca-
tion. This contradictory practice could discredit the entire trans-
plant organization.Conclusions: The necessity of acting vs. the principle of
precaution
For medical, ethical, and emotional reasons, LT in patients with
SAH is a challenging and sensitive procedure, which will
require careful evaluation and transparent communication in
the coming years. According to the results that have been
reported thus far, LT represents a potential new therapeutic
option in SAH that cannot be ignored [3]. Still, this procedure
raises several delicate questions for which it may be useful
to go back to fundamental ethical principles. Major principles
in the Hippocratic Oath are Primum non nocere (ﬁrst do not
harm), the notion of beneﬁcence, meaning to act in the best
interest of the patient, and the notion of justice, meaning a fair
distribution of health resources. Medical ethics also recom-
mend that therapeutic acts have to be performed according
to best scientiﬁc knowledge of the moment. In current medical
knowledge, we may assume that, in the majority of patients
with SAH not responding to medical therapy, abstention, which
may correspond to systematic denial of LT or the imposition of
a period of 6 months of abstinence before decision, would carry
a very high risk of harming the patient. In that sense, on eth-
ical grounds, the necessity of acting, that is, to evaluate the
possibility of an early transplantation, may override the princi-
ple of precaution. In terms of utility also, this is supported by
the ﬁrst results obtained in strictly selected patients, suggest-
ing that LT in these cases represents a valuable use of a scarce
resource. The issue of justice or equity, implying a comparable
opportunity for everyone to receive treatment, remains much
more complex in this setting. In the current situation of organ
shortage, the identiﬁcation of a new indication for transplanta-
tion inevitably penalizes the other patients on the waiting list.
It is at this point that judgmental or moral criteria may inter-
fere with strict medical decisions. To counterbalance this,
objective and reliable selection criteria have to be deﬁned4 vol. 60 j 866–871 869
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and globally accepted, both by transplant professionals and the
public. Extremely selective criteria of the type used in the ﬁrst
study evaluating LT in SAH patients allowed satisfactory results
in terms of survival and alcohol relapse. At the same time, it is
possible that these stringent criteria may also introduce a
source of discrimination, such as partially relying on non-
medical parameters such as a patient’s socio-economic level
[10] that inﬂuences the familial environment and support. At
this stage, despite many unresolved issues, this ﬁrst experience
has opened a door. These initial favorable results should now
be conﬁrmed in longer follow-up studies and by other groups.
Major ethical requirements that dictate that we must not
discriminate against patients in their access to medical
treatment must take precedence over moral considerations
and we should continue to move toward deﬁning the precise
role of this procedure in the future.
Key Points
• Lack of available organs for transplantation imposes
the need to define priorities for graft allocation. 
Selection criteria for transplantation have to reconcile
the objectives of equity, justice, and utility and should
be shared by the transplant community and the general
population
• Severe alcoholic hepatitis refers to a life-threatening
syndrome of liver failure and systemic inflammation
arising in persons who have been consuming excess
amounts of alcohol. In this condition, the absence
of response to medical therapy is associated with
extremely high early mortality
• A first prospective study demonstrated that 
rapid liver transplantation could represent a life-
saving intervention in these patients. In this pilot 
experience, stringent patient selection resulted in
major improvement of short-term survival, and was
associated with low rates of post-transplant alcoholism
relapse
• In the current context of global organ shortage, this
procedure has created controversy in the medical
community and in the public. Reluctance to adopt
this procedure is mainly related to the fact that these
patients have not demonstrated their ability to gain
control over their disease, fears of harmful alcoholic
recidivism, and perceptions that these patients may be
less deserving of a transplant than other patients
• In this situation, principles of medical ethics should
take precedence over moral positions, and the need
for active and non-discriminatory treatment of these
patients with few therapeutic options should encourage
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